Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concentrated safety monitoring of Yunnan Baiyao capsules
ChiCTR-OPC-17013923Phase 4Completed
- Sponsor
- Beijing Tongren Hospital
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Yunnan Baiyao, sponsored by Beijing Tongren Hospital. Primary endpoint: Adverse reactions. Started Jun 2015; status: completed.
02
Drugs
Yunnan Baiyao
Beyond the preview
Go deeper on ChiCTR-OPC-17013923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17013923.